0001645113-21-000067.txt : 20210512 0001645113-21-000067.hdr.sgml : 20210512 20210512161539 ACCESSION NUMBER: 0001645113-21-000067 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210510 FILED AS OF DATE: 20210512 DATE AS OF CHANGE: 20210512 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Benaim Ely CENTRAL INDEX KEY: 0001632237 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 21915271 MAIL ADDRESS: STREET 1: C/O REXAHN PHARMACEUTICALS, INC. STREET 2: 15245 SHADY GROVE ROAD, SUITE 455 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 wf-form4_162085051621853.xml FORM 4 X0306 4 2021-05-10 0 0001645113 NovoCure Ltd NVCR 0001632237 Benaim Ely C/O NOVOCURE INC., 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 0 1 0 0 Chief Medical Officer Ordinary Shares 2021-05-10 4 M 0 1833 47.56 A 35092 D Ordinary Shares 2021-05-10 4 S 0 1833 189.65 D 33259 D Ordinary Shares 2021-05-11 4 S 0 2262 180.118 D 30997 D Options to Buy Ordinary Shares 47.56 2021-05-10 4 M 0 1833 0 D 2029-05-07 Ordinary Shares 1833.0 9165 D Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Fully vested as of the date hereof. By: /s/ Steven Robbins, Attorney in Fact for Ely Benaim 2021-05-12